USD 2.55
(0.0%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2022 | 9.29 Million USD | -34.49% |
2021 | 14.19 Million USD | -37.17% |
2020 | 22.58 Million USD | 36.53% |
2019 | 16.54 Million USD | -1.04% |
2018 | 16.71 Million USD | -12.55% |
2017 | 19.11 Million USD | 5.79% |
2016 | 18.07 Million USD | 21999.64% |
2015 | 81.77 Thousand USD | 368.58% |
2014 | 17.45 Thousand USD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 Q3 | 8.92 Million USD | 39.45% |
2023 Q1 | 9 Million USD | -3.19% |
2023 Q2 | 6.4 Million USD | -28.89% |
2022 Q2 | 14.7 Million USD | 12.36% |
2022 Q3 | 10.06 Million USD | -31.55% |
2022 FY | 9.29 Million USD | -34.49% |
2022 Q1 | 13.09 Million USD | -7.77% |
2022 Q4 | 9.29 Million USD | -7.65% |
2021 FY | 14.19 Million USD | -37.17% |
2021 Q1 | 18.59 Million USD | -17.66% |
2021 Q2 | 10.33 Million USD | -44.45% |
2021 Q3 | 6.84 Million USD | -33.77% |
2021 Q4 | 14.19 Million USD | 107.43% |
2020 Q4 | 22.58 Million USD | 11.16% |
2020 Q3 | 20.31 Million USD | 26.3% |
2020 Q1 | 15.13 Million USD | -8.53% |
2020 Q2 | 16.08 Million USD | 6.32% |
2020 FY | 22.58 Million USD | 36.53% |
2019 Q4 | 16.54 Million USD | 4.64% |
2019 FY | 16.54 Million USD | -1.04% |
2019 Q3 | 15.81 Million USD | -2.84% |
2019 Q2 | 16.27 Million USD | -2.84% |
2019 Q1 | 16.74 Million USD | 0.18% |
2018 Q1 | 21.34 Million USD | 11.67% |
2018 FY | 16.71 Million USD | -12.55% |
2018 Q3 | 16.81 Million USD | -4.77% |
2018 Q2 | 17.65 Million USD | -17.31% |
2018 Q4 | 16.71 Million USD | -0.56% |
2017 Q4 | 19.11 Million USD | 7.19% |
2017 Q1 | 16.91 Million USD | -6.42% |
2017 Q2 | 17.26 Million USD | 2.12% |
2017 FY | 19.11 Million USD | 5.79% |
2017 Q3 | 17.83 Million USD | 3.28% |
2016 Q3 | 18.44 Million USD | 21.11% |
2016 FY | 18.07 Million USD | 21999.64% |
2016 Q2 | 15.22 Million USD | 7.92% |
2016 Q1 | 14.11 Million USD | 17158.14% |
2016 Q4 | 18.07 Million USD | -2.02% |
2015 FY | 81.77 Thousand USD | 368.58% |
2015 Q4 | 81.77 Thousand USD | 193.37% |
2015 Q2 | 20.51 Thousand USD | 0.0% |
2015 Q3 | 27.87 Thousand USD | 35.88% |
2014 FY | 17.45 Thousand USD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Bioceres Crop Solutions Corp. | 501.06 Million USD | 98.144% |
N2OFF, Inc. | 785.65 Thousand USD | -1083.485% |
Arcadia Biosciences, Inc. | 7 Million USD | -32.792% |
Yield10 Bioscience, Inc. | 6.39 Million USD | -45.51% |